Immunogenicity, safety and tolerability of monovalent 2009 pandemic influenza A/H1N1 MF59-adjuvanted vaccine in patients with β-thalassemia major

Vaccine

Volumn 28, Issue 50, 2010, Pages 7825-7828

  Esposito, Susanna ^a   D'Angelo, Emanuela ^a   Daleno, Cristina ^a   Peia, Francesco ^a   Scala, Alessia ^a   Serra, Domenico ^a   Mirra, Nadia ^a   Galeone, Carlotta ^b   Principi, Nicola ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

Author keywords

Adjuvants; Children; MF59; Pandemic A H1N1 influenza virus; Pandemic influenza A H1N1 influenza vaccine; Vaccination

Indexed keywords

INFLUENZA VACCINE; N ACETYLMURAMYLALANYL DEXTRO ISOGLUTAMINYLALANYL DIPALMITOYLPHOSPHATIDYLETHANOLAMINE;

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HUMAN; IMMUNOGENICITY; INFLUENZA A (H1N1); INFLUENZA VIRUS A H1N1; MALE; PANDEMIC INFLUENZA; PRIORITY JOURNAL; SEROCONVERSION; THALASSEMIA MAJOR;

ADJUVANTS, IMMUNOLOGIC; ADOLESCENT; ADULT; ANTIBODIES, VIRAL; ANTIBODY FORMATION; BETA-THALASSEMIA; CHILD; FEMALE; HEMAGGLUTINATION INHIBITION TESTS; HUMANS; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; POLYSORBATES; SQUALENE; YOUNG ADULT;

EID: 78650608963     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2010.09.058     Document Type: Article

References (15)

1. Centers for Disease Control Prevention (CDC), Recommendations of the Advisory Committee on Immunization Practices (ACIP) 2009 prevention and control of seasonal influenza with vaccines. MMWR Morb Mortal Wkly Rep 2009, 58:1-52.
2. Dwyer J., Wood C., McNamara J., Williams A., Andiman W., Rink L., et al. Abnormalities in the immune system of children with β-thalassemia major. Clin Exp Immunol 1987, 68:621-629.
3. Deodlar H.A., Marshall R.J., Barnes J.N. Increased risk of sepsis after splenectomy. BMJ 1993, 307:1408-1409.
4. Sullivan J.L., Ochs H.D., Schiffman G., Hammerschlag M.R., Miser J., Vichinsky E., et al. Immune response after splenectomy. Lancet 1978, 1:178-181.
5. Castagnola E., Fioredda F. Prevention of life-threatening infections due to encapsulated bacteria in children with hyposplenia or asplenia: a brief review of current recommendations for practical purposes. Eur J Haematol 2003, 71:319-326.
6. Brydac L.B., Machala M., Laguna P., Rokicka-Milewska R. Antibody response to influenza vaccination in splenectomized patients in Poland. J Clin Immunol 2004, 24:225-236.
7. Donaldson L.J., Rutter P.D., Ellis B.M., Greaves F.E., Mytton O.T., Pebody R.G., et al. Mortality from pandemic A/H1N1 2009 influenza in England: public health surveillance study. BMJ 2009, 339:b5213.
8. Kelly H., Barr I. Large trials confirm immunogenicity of H1N1 vaccines. Lancet 2010, 375:6-9.
9. Menegon T., Baldo V., Bonello C., Dalla Costa D., Di Tommaso A., Trivello R., et al. Influenza vaccines: antibody responses to split virus and MF59-adjuvanted subunit virus in an adult population. Eur J Epidemiol 1999, 15:573-576.
10. Clark T.W., Pareek M., Hoschler K., Dillon H., Nicholson K.G., Groth N., et al. Trial of 2009 influenza A (H1N1) monovalent MF59-adjuvanted vaccine. New Engl J Med 2009, 361:2424-2435.
11. Nelson J.C., Bittner R.C., Bounds L., Zhao S., Baggs J., Donahue J.G., et al. Compliance with multiple-dose vaccine schedules among older children, adolescents, and adults: results from a vaccine safety datalink study. Am J Public Health 2009, 99(Suppl. 2):S389-S397.
12. Greenberg M.E., Lai M.H., Hartel G.F., Wichems C.H., Gittleson C., Bennet J., et al. Response to a monovalent 2009 influenza A (H1N1) vaccine. New Engl J Med 2009, 361:2405-2413.
13. Vajo Z., Tamas F., Sinka L., Jankovics I. Safety and immunogenicity of a 2009 pandemic influenza A H1N1 vaccine when administered alone or simultaneously with the seasonal influenza vaccine for the 2009-10 influenza season: a multicentre, randomized controlled trial. Lancet 2010, 375:49-55.
14. Hancock K., Veguilla V., Lu X., Zhong W., Butler E.N., Sun H., et al. Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. New Engl J Med 2009, 361:1945-1952.
15. Parkman P.D., Hopps H.E., Rastogi S.C., Meyer H.M. Summary of clinical trials of influenza virus vaccines in adults. J Infect Dis 1977, 136(Suppl.):S722-S730.